Patent 11944718 was granted and assigned to Healthtech Solutions, Inc on April, 2024 by the United States Patent and Trademark Office.
The disclosure herein relates to isolated and purified mammalian fetal allografts and kits and compositions containing these. Also disclosed are methods of preparing isolated and purified mammalian fetal allografts; methods of contacting a wound of a subject with these, and methods of treating a disease or condition with these.